Return to search results

New Advanced Patient Monitoring Device in Northern New Jersey


Patient Monitoring Device
Contact Seller

Asking Price: $4,500,000

Cash Flow: N/A

Gross Revenue: N/A



Inventory: N/A

Established: 2013

New Advanced Patient Monitoring Device in Northern New Jersey

Save Print Share Valuation Report

Business Description

This firm is seeking funding to take a new advanced patient monitoring device from fully functional and clinically tested prototype stage to commercial stage. The device, called a "Pulse Flowmeter, is potentially disruptive technology in the operating room, recovery room and intensive care unit, changing, in a fundamental way, doctors' approach to these acute care patients. The Pulse Flowmeter detects blood loss and heart failure very early, before there are changes in blood pressure. This can allow physicians to treat and thereby prevent their patients from going into shock. The Pulse Flowmeter does this measuring peripheral perfusion (blood flow in the arms and legs), which decreases very early as a patient is heading in the direction of developing shock. The initial target market is very large, including operating rooms, recovery rooms, surgi-centers and intensive care units. This is a platform technology with many other uses, other than those stated above. Other markets to be addressed with different versions of the device include management of chronic congestive heart failure, triaging injured soldiers on the battlefield and the management of peripheral vascular disease.

Attached Documents

Detailed Information

There are no devices other than the Pulse Flowmeter that provide robust, safe, non-invasive measurement of peripheral blood flow. In that sense, there is no competition for the Pulse Flowmeter. However, cardiac output monitors, if used judiciously may also provide information regarding the patient's volume status.
Growth & Expansion:
Business Model: This business model has sometimes been called “razor blade/razor.” There is the single purchase of a base item, in this case, the Pulse Flowmeter. But then, there is ongoing revenue from the use of a disposable, in this case, the electrode. Competitive technologies use an expensive disposable. This results in use of these devices in high risk patients only. In our business model, the disposable will be inexpensive, so that the device could economically be used on all patients undergoing surgery. Strengths • The Pulse Flowmeter solves a specific well identified problem in the medical community • The Pulse Flowmeter is a unique product. It is the only non-invasive device that provides continuous, robust measurement of peripheral blood flow which is of great interest to physicians caring for patients at risk of bleeding and/or hemodynamic instability. • There are multiple physician groups that desire this information including anesthesiologists, surgeons, intensivists and emergency room doctors. • The management team includes a successful serial entrepreneur, the inventor of the device, a seasoned CEO of a successful medical device company and seasoned technical managers • Use of the Pulse Flowmeter will save hospitals money by reducing unnecessary blood transfusions and shortening or eliminating ICU stay • The addressable market is very large • The market is well defined and reachable through existing distribution channels • The device uses a disposable that will be sold in high volume and provide a source of recurring income • Barriers to entry include multiple patents and significant technical knowhow • The Pulse Flowmeter is a platform technology. With modifications, it can be used in the management of dialysis patients, heart failure patients and patients with peripheral vascular disease. Summary of the Projected Market The addressable domestic market includes 76,200 operating rooms, 114,300 recovery room beds and 78,000 ICU beds for a total of 268,500 Pulse Flowmeters. In addition, each use requires a disposable proprietary electrode. In the US alone, there are 38 million surgical cases per year and 5.7 million ICU patients per year (2 electrodes per ICU stay) for a total of 49.4 million disposables per year. Thus, at our projected sales prices, the addressable domestic sales potential is $2.7 billion for monitors and $1.2 billion per year for disposables. SALES PROJECTIONS The expected price of the monitors is $15,000 and the disposable $25. The total addressable market (domestic only) for the initial target applications is 268,500 monitors ($4 billion) and 49.4 million electrodes per year ($1.2 billion/yr). Predicting market penetration by year 5 results in monitor sales of $19.3 million and annual electrode sales of $4.1 million. Projected Sales and Market Share The estimate of market share has been extremely conservative, primarily because clinicians tend to be slow to adopt new technologies. Fortunately, the target market, anesthesiologists, tend to be much more open to new technologies than most other physicians. They are always looking for new information that can give them a better sense of the cardiovascular status of their patients and, therefore, have been at the forefront of adopting new patient monitoring technology. The market share has been estimated at only 0.02% for the first year of sales (54 units) and annual growth of only 0.10%.
Contact Seller

Contact the Seller

Contact Seller Loading

Jack Armstrong

Business Listed By:
Jack Armstrong

Sunbelt Business Brokers of NJ

Show Phone Number

View My Listings

Memberships & Certifications:
Indicates membership in the International Business Brokers Association (IBBA). The IBBA is the only certifying organization for Business Brokers and Intermediaries who assists people in buying or selling a business.

Listing Statistics

Saved This Listing:
Days Active On Site:
Appeared in Search:
Listing Detail Views:

Ad#:1494756 Report an issue with this listing

The information in this listing has been provided by the business seller or representative stated above. BizBuySell has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness.
Read BizBuySell's Terms of Use before responding to any ad.

Similar Listings

HOS Solutions

Franchise Opportunity
Capital Required: $24,950